SkinHealth Systems Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $290M-13.2% YoYTTM through 30 Jun 2026
Net Income -$28.4MTTM through 30 Jun 2026
Free Cash Flow $21.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 65.3% |
| EBITDA Margin | 6.1% |
| Operating Margin | -6.9% |
| Net Margin | -9.8% |
Returns
-15.6%ROE
-1.9%ROA
Balance Sheet Health
Debt / Equity3.94x
Current Ratio1.79x
Net Debt$7.7M
Cash & Equivalents$206.1M
Quality Metrics
Altman Z-Score-0.51
Piotroski F-Score6 / 9
FCF Margin7.3%
Rule of 407.4
Earnings-Beat Rate66.7%
Multi-Year Trend
RevenueFY2025: $300.8M
Diluted EPS-$0.21TTMFY2025: $-0.07
Dividend
No dividend
Capital Allocation
R&D Spend$5.9M
Capex Intensity0.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Consumables | $212.7M | +1.8% | View detailsExpected to remain a resilient recurring revenue driver as the active install base utilizes Hydrafacial systems. |
| Delivery Systems | $88.1M | -29.7% | View detailsContinued pressure on device sales expected in the near term due to challenging macroeconomic conditions. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.